SHE — Shedir Pharma Srl Unipersonale Balance Sheet
0.000.00%
- €55.45m
- €52.75m
- €59.39m
- 97
- 81
- 95
- 100
Annual balance sheet for Shedir Pharma Srl Unipersonale, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 6.1 | 16.4 | 19.1 | 15.8 | 1.23 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 14 | 12.1 | 12.2 | 16.1 | 17.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 34.9 | 40.8 | 40.7 | 44.1 | 41.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6.64 | 5.97 | 5.88 | 5.05 | 7.84 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 47.8 | 52.7 | 52.6 | 56.8 | 56.1 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 17.2 | 12.6 | 14.4 | 16.4 | 14.4 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 25.3 | 26.1 | 24.5 | 24 | 20.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 22.6 | 26.7 | 28.1 | 32.8 | 36 |
Total Liabilities & Shareholders' Equity | 47.8 | 52.7 | 52.6 | 56.8 | 56.1 |
Total Common Shares Outstanding |